Last updated on December 2019

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)


Brief description of study

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Clinical Study Identifier: NCT02876835

Find a site near you

Start Over

GSK Investigational Site

Aalst, Belgium
8.73miles
  Connect »